SMART DAK Cervical Cancer Screening, published by Dan Heslinga (independent contributor). This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/dhes/smart-dak-cxca/ and changes regularly. See the Directory of published versions

Concepts

Key clinical concepts referenced across this DAK are defined in the CXCA.D CodeSystem. For the methodology vocabulary distinguishing legal, programmatic, and operational regulatory positions, see the CXCA.Bindingness CodeSystem.

The DAK uses standard FHIR primitives and conventions throughout (R4); no cxca-specific glossary or abbreviations file is maintained beyond the CodeSystem displays and definitions. For a brief abbreviation list (CIN, HPV, ASC-US, HSIL, LSIL, NILM, LTFU, etc.), the CXCA.D CodeSystem entries provide expansion and clinical context.

Mongolia-specific abbreviations from the source guideline (УХХХ for cervical cancer, ХПВ for HPV, the ЭИМ-5 form codes, etc.) are not currently rendered as DAK concepts but are documented in the methodology overview at Adapting Guidelines for Country Use.